NCT06324968View on ClinicalTrials.gov

Ro60 Expression in Macrophages in Sjogren's Disease

NAActive, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 9, 2024

Primary Completion Date

December 13, 2024

Study Completion Date

May 9, 2025

Conditions
Sjogren's Syndrome
Interventions
DIAGNOSTIC_TEST

Positive serology for anti-SSA

Blood sample which detect serology for anti-SSA.

Trial Locations (1)

06000

CHU Nice, Nice

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER

NCT06324968 - Ro60 Expression in Macrophages in Sjogren's Disease | Biotech Hunter | Biotech Hunter